| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50268-549-15 | 50268-549 | HUMAN PRESCRIPTION DRUG | Methenamine Hippurate | Methenamine Hippurate | TABLET | ORAL | 20201202 | N/A | ANDA | ANDA212172 | AvPAK | METHENAMINE HIPPURATE | 1000 mg/1 | 50 BLISTER PACK in 1 CARTON (50268-549-15) / 1 TABLET in 1 BLISTER PACK (50268-549-11) |
| 60687-694-21 | 60687-694 | HUMAN PRESCRIPTION DRUG | Methenamine Hippurate | Methenamine Hippurate | TABLET | ORAL | 20220812 | N/A | ANDA | ANDA212172 | American Health Packaging | METHENAMINE HIPPURATE | 1000 mg/1 | 30 BLISTER PACK in 1 CARTON (60687-694-21) / 1 TABLET in 1 BLISTER PACK (60687-694-11) |
| 42571-332-01 | 42571-332 | HUMAN PRESCRIPTION DRUG | Methenamine Hippurate | Methenamine Hippurate | TABLET | ORAL | 20190815 | N/A | ANDA | ANDA212172 | Micro Labs Limited | METHENAMINE HIPPURATE | 1000 mg/1 | 100 TABLET in 1 BOTTLE (42571-332-01) |
| 42571-332-23 | 42571-332 | HUMAN PRESCRIPTION DRUG | Methenamine Hippurate | Methenamine Hippurate | TABLET | ORAL | 20190815 | N/A | ANDA | ANDA212172 | Micro Labs Limited | METHENAMINE HIPPURATE | 1000 mg/1 | 80 TABLET in 1 CARTON (42571-332-23) |